Eris Lifesciences has scheduled a meeting with analysts and investors on August 27 at 10:30 am. The session will be a one-on-one interaction with HBM Partners AG.

Meeting details

The company has announced the upcoming interaction with the investment community. The session is set to bring together analysts and investors for a direct engagement with the company. Mr. Amit Bakshi will represent the management during the in-person meeting.

The schedule is indicative and subject to change. The company stated that no unpublished price sensitive information will be discussed.

Eris Lifesciences Limited will host a one-on-one virtual meeting with Tokio Marine Asset Management Co. Ltd. on Monday, Aug 17, 2026, at 12:00 PM IST. The interaction aims to update institutional investors on the company’s business performance and strategic outlook using only publicly available information. This disclosure ensures transparency in investor relations while adhering to regulatory standards regarding unpublished price-sensitive information.

The meeting was disclosed pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. Management representative Krishnakumar Vaidyanathan will lead the discussion on behalf of the company. The schedule is indicative and remains subject to change due to unforeseen developments.

Meeting Details

The company emphasized that no unpublished price-sensitive information (UPSII) will be discussed during the session. All references made by management will be drawn from publicly available documents. Milind Talegaonkar, Company Secretary & Compliance Officer, signed the intimation submitted to BSE Limited and National Stock Exchange of India Limited.

Regulatory Compliance

This disclosure aligns with SEBI’s mandate for listed entities to report interactions with analysts and institutional investors. The requirement prevents selective disclosure of material information, ensuring all shareholders have equal access to significant updates. Eris Lifesciences continues its routine engagement with key financial institutions to maintain market confidence and liquidity.